Resource Guide: FDA warning Tysabri Progressive Multifocal Leukoencephalopathy

This page collects vetted references on medical safety, regulatory guidance, and clinical background for anyone researching this topic.

Featured analysis

FDA warning Tysabri Progressive Multifocal Leukoencephalopathy

A focused review of background, context, and source material on this subject.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.

National Institutes of Health (NIH)

Reference: National Institutes of Health (NIH)

Authoritative source for clinical, regulatory, and public-health background reading.

Centers for Disease Control and Prevention (CDC)

Reference: Centers for Disease Control and Prevention (CDC)

Authoritative source for clinical, regulatory, and public-health background reading.